Australia markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.60-0.25 (-2.11%)
At close: 04:00PM EDT
11.16 -0.44 (-3.79%)
After hours: 06:03PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4465
Avg. Estimate-0.12-0.12-0.47-0.44
Low estimate-0.18-0.17-0.71-0.85
High estimate-0.06-0.08-0.35-0.15
Year ago EPS-0.14-0.18-0.49-0.47
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4366
Avg. Estimate23.43M25.47M96.7M117.24M
Low estimate23.06M24.31M92.61M104.72M
High estimate24M26.8M100.1M133M
Year ago sales20.75M20.45M84.82M96.7M
Sales growth (year/est)12.90%24.50%14.00%21.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.24-0.19-0.2-0.14
Actual EPS-0.14-0.18-0.02-0.15
Difference0.10.010.18-0.01
Surprise %41.70%5.30%90.00%-7.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.12-0.12-0.47-0.44
7 days ago-0.12-0.13-0.49-0.36
30 days ago-0.12-0.12-0.46-0.34
60 days ago-0.12-0.12-0.46-0.34
90 days ago-0.22-0.22-0.78-0.89
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A121
Up last 30 days1231
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A12
Growth estimatesYMABIndustrySector(s)S&P 500
Current qtr.14.30%N/AN/AN/A
Next qtr.33.30%N/AN/AN/A
Current year4.10%N/AN/AN/A
Next year6.40%N/AN/AN/A
Next 5 years (per annum)-88.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A